JHL Biotech

OverviewSuggest Edit

JHL Biotech is a biopharmaceutical company that develops biosimilars. It also accelerates the development programs of distinguished clients and partners through the provision of contract development and manufacturing services.

Latest Updates

Employees (est.) (Apr 2021)103(-2%)
Cybersecurity ratingBMore

Key People/Management at JHL Biotech

Allen Ho

Allen Ho

Senior Director of Regulatory Technical CMC
Mahalia Corrales

Mahalia Corrales

Senior Director of Process Development & Technology
Yen Hsieh

Yen Hsieh

Compliance Officer, Vice President of Corporate HR and Taiwan Supporting Operation
James Huang

James Huang

Executive Chairman and CEO
Show more

JHL Biotech Office Locations

JHL Biotech has an office in
Show all (1)

JHL Biotech Financials and Metrics

Summary Metrics

Founding Date


JHL Biotech total Funding

$266.6 m

JHL Biotech latest funding size

$106 m

Time since last funding

3 years ago

JHL Biotech investors

JHL Biotech's latest funding round in May 2018 was reported to be $106 m. In total, JHL Biotech has raised $266.6 m
Show all financial metrics

JHL Biotech Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

JHL Biotech Online and Social Media Presence

Embed Graph

JHL Biotech Blogs

Eden Biologics Proudly Announces Dr. Scott Liu as Board Member

Hsinchu, Taiwan, March 15th, 2021 – Eden Biologics is honored to announce the addition of Dr. Scott Liu as a member of the Eden Board of Directors.  Effective March 15, 2021, Dr. Liu will be added to a team of top global biotech executives and guide Eden in achieving its mission: To make world-class…

Eden Biologics Anticipates Initiation of Global Phase 3 in 2021 H2 for Its Denosumab Biosimilar

Hsinchu, Taiwan, 25th February, 2021 – Eden Biologics, Inc., a global frontrunner in biological drug development and manufacturing platform technologies, today announced completion of enrollment for their Phase 1 comparative PK Clinical Trial (JHL-CLIN-1266-01) of Eden’s lead product candidate EB100…

JHL Biotech Officially Changes Name to EDEN Biologics

Hsinchu, Taiwan, February 19, 2021 – JHL Biotech, Inc., a global frontrunner in large-molecule biological drug development and manufacturing platform technologies, is excited to announce today that it has changed its corporate name to Eden Biologics, Inc.  The name change reflects the company’s cont…

JHL to Participate in 2020 Biopharma Summit

JHL Biotech is proud to present our very own sponsored event called the 2020 Biopharma Summit, bringing together a vast panel of speakers and panelists within the Taiwan Biotechnology & Manufacturing Industry.  Please join us as one of the hundreds of attendees who are interested in learning abo…

JHL Biotech Frequently Asked Questions

  • When was JHL Biotech founded?

    JHL Biotech was founded in 2012.

  • Who are JHL Biotech key executives?

    JHL Biotech's key executives are Allen Ho, Mahalia Corrales and Yen Hsieh.

  • How many employees does JHL Biotech have?

    JHL Biotech has 103 employees.

  • Who are JHL Biotech competitors?

    Competitors of JHL Biotech include Mycenax Biotech, Neuro-Zone and 2bind.

  • Where are JHL Biotech offices?

    JHL Biotech has an office in.

  • How many offices does JHL Biotech have?

    JHL Biotech has 1 office.